Best Stocks Under $1 to Buy Today: May 23, 2025
| Number | Ticker | Country | Founded | IPO Year | Price | Revenue | Analyst Decision | Analyst Count |
|---|---|---|---|---|---|---|---|---|
| 1 | United States | 2015 | 2021 | $0.18 | $0.00 | Buy | 6 | |
| 2 | Canada | 1998 | 1999 | $0.42 | $0.00 | Strong Buy | 4 | |
| 3 | United States | 1971 | 1990 | $0.48 | $16,886,419.00 | Strong Buy | 3 | |
| 4 | United States | 1996 | N/A | $0.30 | $5,824,000.00 | Strong Buy | 3 | |
| 5 | United States | 1997 | N/A | $0.85 | $35,332,238.00 | Buy | 2 | |
| 6 | United States | 2015 | 2021 | $0.69 | $0.00 | Strong Buy | 4 | |
| 7 | United States | 2014 | N/A | $0.54 | $11,732,000.00 | Strong Buy | 3 | |
| 8 | United States | 2010 | 2014 | $0.74 | $272,251,000.00 | Strong Buy | 4 | |
| 9 | Israel | 2011 | N/A | $0.83 | $183,000.00 | Strong Buy | 3 | |
| 10 | United States | 2012 | 2023 | $0.32 | $0.00 | Strong Buy | 3 | |
| 11 | United States | 2016 | N/A | $0.91 | $0.00 | Strong Buy | 6 | |
| 12 | KAPAKAIROS PHARMA LTD | United States | 2013 | 2024 | $0.55 | $0.00 | Strong Buy | 3 |
| 13 | United Kingdom | 1997 | 2017 | $0.04 | $0.00 | Buy | 2 | |
| 14 | United States | 2005 | N/A | $0.28 | $17,544,000.00 | Strong Buy | 2 | |
| 15 | United States | 1995 | 2013 | $0.74 | $495,670,000.00 | Strong Buy | 2 | |
| 16 | United States | 2016 | 2021 | $0.14 | $0.00 | Strong Buy | 2 | |
| 17 | United States | 1999 | 2011 | $0.93 | $169,687,000.00 | Buy | 2 | |
| 18 | United States | 2017 | 2019 | $0.84 | $0.00 | Strong Buy | 3 | |
| 19 | United States | 2000 | 2010 | $0.94 | $152,357,000.00 | Buy | 9 | |
| 20 | United States | 2005 | 2021 | $0.29 | $0.00 | Strong Buy | 4 | |
| 21 | United States | 1996 | N/A | $0.51 | $23,682,000.00 | Strong Buy | 2 |
Share on Social Networks:
Disclaimer
The FinQuota filters have identified what they believe to be the "Best Under $1 Stocks to Buy on May 23, 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.